Lightway Medical Solutions Inc Bellingham, MA - 02019

Lightway Medical Solutions Inc is categorized under Communications in Bellingham, MA and active since 2008.

Lightway Medical Solutions Inc was established in 2008, and today employs 1 to 4, earning $100.000 to $499.999 per year. This is a Communications business, which does work in the BOTH market, and is classified as a Communications, under code number 5416183 by the NAICS.

If you are seeking more information, feel free to contact Garry Russell, Owner at the company’s single location by writing to 39 Ray Avenue, Bellingham, Massachusetts MA 02019 or by phoning (508) 966-0123. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Lightway Medical Solutions Inc
Contact Person: Garry Russell, Owner
Address: 39 Ray Avenue, Bellingham, Massachusetts 02019
Phone Number: (508) 966-0123
Website Address: lightwayms.com
Annual Revenue (USD): $100.000 to $499.999
Founded: 2008
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B & B2C
Business Category: Communications
SIC Code: 4899
NAICS Code: 5416183
Share This Business:

Lightway Medical Solutions Inc was started in 2008 to provide professional Communications under the SIC code 4899 and NAICS code 5416183. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $100.000 to $499.999 per annum.

Feel free to contact Garry Russell, Owner for inquiries that concern Lightway Medical Solutions Inc by calling the company number (508) 966-0123, as your correspondence is most welcome. Additionally, the physical location of the single location of Lightway Medical Solutions Inc can be found at the coordinates 42.119741,-71.449405 as well as the street address 39 Ray Avenue in Bellingham, Massachusetts 02019.

For its online presence, you may visit Lightway Medical Solutions Inc’s website at lightwayms.com and engage with its social media outlets through on Twitter and on Facebook.